Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for EPIDIOLEX
- Clinical Study to Evaluate Cannabidiol Liver Enzyme Elevations and Drug Interactions
- Safety and Effect on Pain and Function According to RAPID-3 of IHL-675A in Patients With Rheumatoid Arthritis
- A Study to Investigate Behavioral and Other Co-Occurring Outcomes With Epidiolex as Add-On Therapy in Participants Aged 1 to 65 Years of Age With Tuberous Sclerosis Complex
- Cannabidiol to Reduce Anxiety Reactivity: A Randomized Controlled Trial in Social Anxiety Disorder
- Phytocannabinoids for the Treatment of Chronic Chemotherapy-Induced Peripheral Neuropathy in Breast and Colon Cancer Survivors
- Investigating the Effects of Cannabidiol on Social Anxiety Disorder
- Effects of Cannabidiol and Tetrahydrocannabinol on Microbiome and Neuroinflammation in HIV
- Topical Cannabidiol for the Treatment of Chemotherapy-Induced Peripheral Neuropathy
- Epidiolex® for Anxiety in Pediatric Epilepsy
- Efficacy and Safety of GWP42003-P Oral Solution in Children With Epilepsy With Myoclonic-atonic Seizures
- Pharmacokinetic Investigation of BSPG Laboratories (BSPG) Cannabidiol in Healthy Participants
- Enhancing Prolonged Exposure With Cannabidiol to Treat Posttraumatic Stress Disorder in Military Veterans
- Cannabidiol for Reduction of Brain Neuroinflammation
- Assessment of Potential for Chronic Liver Injury in Participants Treated With Epidiolex (Cannabidiol) Oral Solution
- Investigation of the Pharmacokinetic Profile of Nanoemulsion CBD
- Investigating the Potential Role of a Novel Quadrate Combination Therapy Mifepristone(Antiprogestrone), Tamoxifen, Retinoic Acid and Cannabidiol ( Selective Cyp 26 Inhibitor) for Treating Early Breast Cancer.
- Cannabinoid Interactions With Central and Peripheral Pain Mechanisms in Osteoarthritis of the Knee
- Epidiolex in Obsessive Compulsive Disorder
- Epidiolex in Typical Absence Seizures
- Role of CBD in Regulating Meal Time Anxiety in Anorexia Nervosa
- Cannabidiol (CBD) for Treatment of Aromatase Inhibitor-Associated Arthralgias
- Cannabidiol for Bilateral Total Knee Arthroplasty
- Cannabidiol for Treatment Resistant Depression
- Efficacy of Epidiolex in Patients With Electrical Status Epilepticus of Sleep (ESES).
- CBD for Dental Pain
- Cannabidiol and CES1 Interactions in Healthy Subjects
- Neuroimaging and CBD for Heroin Use Disorder
- Trial of Cannabidiol to Treat Severe Behavior Problems in Children With Autism
- Safety, Pharmacokinetics, and Exploratory Efficacy Assessment of Adjunctive Cannabidiol Oral Solution (GWP42003-P) Compared With Standard of Care Antiepileptic Therapy, in Patients Age 1 Month to <12 Months of Age With Tuberous Sclerosis Complex Who
- RCT of CBD for Anxiety in Advanced Breast Cancer
- Novel Cognitive Treatment Targets for Epidiolex in Sturge- Weber Syndrome
- Epidiolex (CBD) in Patients With Biochemically Recurrent Prostate Cancer
- Effect of Non-psychoactive Cannabidiol as an Adjunct to Botulinum Toxin in Blepharospasm
- CBD-Microglia PET Study
- A Study to Assess the Effect of Cannabidiol Oil on Pain After Ureteroscopy for Kidney Stones
- An Open-label Extension Study of Cannabidiol Oral Solution (GWP42003-P, CBD-OS) in Patients With Rett Syndrome
- Oral Cannabidiol for Opioid Withdrawal
- Effects of Cannabis on Cognition and Endocannabinoid Levels in Bipolar Disorder Patients and Healthy Volunteers
- Cannabidiol Use to Reduce Cravings in Individuals With Opioid Use Disorder on Buprenorphine
- Investigation of Cognitive Outcomes With Cannabidiol Oral Solution
- Cannabidiol for Treatment of Recent-onset Psychosis With Comorbid Cannabis Use
- Cannabidiol for Alcohol Use Disorder
- Cannabidiol for ASD Open Trial
- Investigation of Cannabidiol for Reduction of NeuroInflammation in Chronic Back Pain
- Efficacy and Safety of Cannabidiol Oral Solution (GWP42003-P, CBD-OS) in Patients With Rett Syndrome
- Cannabidiol Pharmacotherapy for Adults With Cannabis Use Disorder
- University of Alabama at Birmingham (UAB) Adult CBD Program
- University of Alabama at Birmingham (UAB) Pediatric CBD Program
- An Open-label Extension Trial to Investigate Possible Drug-drug Interactions Between Stiripentol or Valproate and Cannabidiol in Patients With Epilepsy
- A Study of Possible Drug-drug Interactions Between Stiripentol or Valproate and Cannabidiol in Patients With Epilepsy
- A Randomized Controlled Trial to Investigate Possible Drug-drug Interactions Between Clobazam and Cannabidiol
- An Open-label Extension Study to Investigate Possible Drug-drug Interactions Between Clobazam and Cannabidiol
- Epidiolex and Drug Resistant Epilepsy in Children
- Cannabidiol Expanded Access Study in Medically Refractory Sturge-Weber Syndrome
- GWPCARE2 A Study to Investigate the Efficacy and Safety of Cannabidiol (GWP42003-P) in Children and Young Adults With Dravet Syndrome
- A Study to Investigate the Efficacy and Safety of Cannabidiol (GWP42003-P; CBD) as Adjunctive Treatment for Seizures Associated With Lennox-Gastaut Syndrome in Children and Adults
- GWPCARE5 - An Open Label Extension Study of Cannabidiol (GWP42003-P) in Children and Young Adults With Dravet or Lennox-Gastaut Syndromes
- Efficacy and Safety of GWP42003-P for Seizures Associated With Lennox-Gastaut Syndrome in Children and Adults
- Antiepileptic Efficacy Study of GWP42003-P in Children and Young Adults With Dravet Syndrome (GWPCARE1)
- A Dose-ranging Pharmacokinetics and Safety Study of GWP42003-P in Children With Dravet Syndrome (GWPCARE1)
- A Study of GWP42003 as Adjunctive Therapy in the First Line Treatment of Schizophrenia or Related Psychotic Disorder
Clinical trials list
click for details